产品
编 号：F761353
产品类型
规格
价格
是否有货
1mg
询价
询价
5mg
询价
询价
结构图
CAS No: 910649-32-0
产品详情
生物活性：
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma.
体内研究：
Anrukinzumab (IMA-638; 10 mg/kg; intravenous infusion; single) 减少食蟹猕猴肺部炎症模型中的肺部炎症。Animal Model:Adult male cynomolgus monkeys (6 to 10 kg; cynomolgus monkey model of lung inflammation).
Dosage:10 mg/kg
Administration:Intravenous infusion; single
Result:Reduced total BAL cell count, eosinophil number, and neutrophil number.Reduced the levels of eotaxin and RANTES in BAL fluid.
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma.
体内研究：
Anrukinzumab (IMA-638; 10 mg/kg; intravenous infusion; single) 减少食蟹猕猴肺部炎症模型中的肺部炎症。Animal Model:Adult male cynomolgus monkeys (6 to 10 kg; cynomolgus monkey model of lung inflammation).
Dosage:10 mg/kg
Administration:Intravenous infusion; single
Result:Reduced total BAL cell count, eosinophil number, and neutrophil number.Reduced the levels of eotaxin and RANTES in BAL fluid.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备